VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
QNCX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
QNCXQuince Therapeutics, Inc.
$17.50$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksQNCXQuarterly Financials

Quince Therapeutics, Inc. (QNCX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Quince Therapeutics, Inc. (QNCX) quarterly income statement — complete revenue, gross profit & net income history

QNCX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold36K0035K016K000304K0000000000
COGS % of Revenue--------------------
Gross Profit-36K00-35K0-16K000-304K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%---94.74%--------------
Operating Expenses11.08M19.35M13.43M9.86M14.86M10.09M5.86M28.19M11.22M8.04M6.09M5.58M12.96M6.32M7.62M16.26M21.86M23.54M21.68M21.78M
OpEx % of Revenue--------------------
Selling, General & Admin4.27M3.63M3.28M3.34M4.79M4.27M3.63M4.7M4.97M4.61M4.66M4.23M3.83M3.55M4.34M9.06M9.11M8.33M7.64M7.06M
SG&A % of Revenue--------------------
Research & Development6.84M12.6M8.08M6.55M8.14M5.83M4.92M4.15M3.7M3.43M1.43M1.35M3.23M2.77M2.45M7.2M12.76M15.21M14.04M14.72M
R&D % of Revenue--------------------
Other Operating Expenses-36K1000K1000K-35K1000K0-1000K1000K1000K0001000K0825K00000
Operating Income-11.11M-19.35M-13.43M-9.89M-14.86M-10.11M-5.86M-28.19M-11.22M-8.34M-6.09M-5.58M-12.96M-6.32M-7.62M-16.26M-21.86M-23.54M-21.68M-21.78M
Operating Margin %--------------------
Operating Income Growth %25.21%-91.44%-129.06%64.9%-32.45%-21.17%3.79%-404.87%13.41%-32.03%20.03%65.65%40.74%73.16%64.85%25.36%6.22%-12.91%1.07%-19.22%
EBITDA-11.08M-19.31M-13.39M-9.86M-14.83M-10.09M-5.78M-28.15M-11.18M-8.04M-5.35M-5.58M-12.94M-6.28M-7.58M-16.17M-21.82M-23.46M-21.59M-21.7M
EBITDA Margin %--------------------
EBITDA Growth %25.29%-91.36%-131.85%64.97%-32.64%-25.55%-7.96%-404.17%13.61%-28.07%29.41%65.48%40.71%73.24%64.89%25.45%6.04%-12.97%1.09%-19.27%
D&A (Non-Cash Add-back)36K39K36K35K32K16K86K44K40K304K01K17K42K40K84K38K84K87K87K
EBIT30.57M-16.24M-11.36M-15.98M-12.93M-12.45M-8.55M-8.84M-8.67M-8.84M-5.35M-4.89M-7.06M-5.53M-6.79M-16.85M-21.64M-23.4M-21.71M-21.75M
Net Interest Income160K227K300K311K406K536K683K823K887K1.01M959K805K700K536K315K145K72K105K128K160K
Interest Income160K227K300K311K406K536K683K823K887K1.01M959K805K700K536K315K145K72K105K128K160K
Interest Expense00000000000000000000
Other Income/Expense41.69M-16.96M-58K-6.09M-125K-2.34M384K499K100K-500K743K698K454K785K-301K-590K222K145K-29K29K
Pretax Income30.57M-36.31M-13.49M-15.98M-14.98M-12.45M-5.48M-27.69M-11.12M-8.84M-5.35M-4.89M-12.5M-5.53M-7.92M-16.85M-21.64M-23.4M-21.71M-21.75M
Pretax Margin %--------------------
Income Tax-5.34M3.15M-46K67K47K7K13K36K31K51K00-248K00-284K0000
Effective Tax Rate %-17.46%-8.66%0.34%-0.42%-0.31%-0.06%-0.24%-0.13%-0.28%-0.58%0%0%1.98%0%0%1.69%0%0%0%0%
Net Income35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M-5.35M-4.89M-12.25M-5.53M-7.92M-16.56M-21.64M-23.4M-21.71M-21.75M
Net Margin %--------------------
Net Income Growth %338.94%-216.73%-144.76%42.12%-34.81%-40.07%-2.63%-467.52%9.02%-60.72%32.45%70.5%43.38%76.35%63.51%23.86%6.26%-13.84%-0.93%-23.52%
Net Income (Continuing)35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M-5.35M-4.89M-12.25M-5.53M-7.92M-16.56M-21.64M-23.4M-21.71M-21.75M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)143.40-150.00-50.00-68.00-68.00-56.00-26.00-128.00-52.00-44.00-30.00-28.00-68.00-32.00-46.00-102.00-142.00-158.00-146.00-148.00
EPS Growth %310.88%-167.86%-92.31%46.88%-30.77%-27.27%13.33%-357.14%23.53%-37.5%34.78%72.55%52.11%79.75%68.49%31.08%8.97%-12.86%0%-23.33%
EPS (Basic)143.40-150.00-50.00-68.00-68.00-56.00-26.00-128.00-52.00-44.00-30.00-28.00-68.00-32.00-46.00-102.00-142.00-158.00-146.00-148.00
Diluted Shares Outstanding250.49K250.49K269.76K233.43K219.71K216.31K215.82K215.48K215.05K204.87K180.37K179.59K179.28K180.68K178.06K162.34K150.67K148.84K148.84K147.94K
Basic Shares Outstanding250.49K250.49K269.76K233.43K219.71K216.31K215.82K215.48K215.05K204.87K180.37K179.59K179.28K180.68K178.06K162.34K150.67K148.84K148.84K147.94K
Dividend Payout Ratio--------------------